...
Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making.

MD MRCGP DFFP
Was this answer helpful?
Authored and medically reviewed by Dr Farzana Khan on 21 July 2026
Rate Dr Farzana's explanation
Differentiating between localised vulval intraepithelial neoplasia lesions ... | WHC Clinical FAQ

Differentiating between localised vulval intraepithelial neoplasia lesions ... | WHC Clinical FAQ

Differentiating between localised vulval intraepithelial neoplasia lesions ... | WHC Clinical FAQ

Differentiating between localised vulval intraepithelial neoplasia lesions ... | WHC Clinical FAQ

How does a clinician evaluate a non-healing vulvar ulcer in a patient with ... | WHC Clinical FAQ

How does a clinician evaluate a non-healing vulvar ulcer in a patient with ... | WHC Clinical FAQ

Differentiating lichen sclerosus from vulvar intraepithelial neoplasia (VIN).

Differentiating lichen sclerosus from vulvar intraepithelial neoplasia (VIN).




Lesion safety


Biopsy threshold


Do not delay

Women’s Health Clinic FAQ

Differentiating between localised vulval intraepithelial neoplasia lesions and inflammatory dermatoses during pain assessments.

A persistent painful vulval or vestibular lesion needs careful assessment because VIN or early squamous cell carcinoma can sometimes mimic inflammation.

Direct answer

VIN and inflammatory dermatoses can overlap visually, so persistent focal lesions, colour change, ulceration or pain may require biopsy rather than symptom treatment alone. The safest approach is to localise the pain, examine the skin and mucosa, check discharge or infection where relevant, and decide whether swabs, microscopy, pH testing, biopsy or specialist vulval review are needed. This avoids reducing persistent dyspareunia to thrush, dryness or friction alone.

The safest answer is explicit about biopsy thresholds while avoiding alarmist language or false reassurance.


Educational only. Suitability and next steps should be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation about differentiating between localised vulval intraepithelial neoplasia lesions and inflammatory dermatoses during pain assessments.

Lesion safety

At a glance

These are the main points to understand before deciding whether painful sex is linked to skin, discharge, infection, allergy, scarring, mechanics or a focal lesion.

At a glance

Clinical summary

Main area

Focal lesion

Pattern

Persistent pain

Watch for

Non-healing lesion

Next step

Biopsy decision

Important safety note

A persistent painful, changing, bleeding, ulcerated, thickened, pigmented or non-healing lesion needs prompt clinical assessment and possible biopsy.

Pain
Skin
Swabs
Biopsy
Review




Detailed answer

Detailed answer

The deeper answer starts by separating entrance pain, deep pain, vestibular pain, discharge, dermatoses, fissures, scarring, allergy and focal lesions.

Direct answer

The reader needs to know when focal vulval or vestibular pain might represent VIN or early cancer rather than inflammatory disease alone.

Anatomy
Cause
Testing
Safety

Direct answer

Persistent focal lesions need a lower threshold for specialist review.

Lesion assessment

VIN, early cancer and inflammatory dermatoses can overlap in appearance.

Inflammatory mimics

Non-healing, changing, bleeding, thickened or atypical lesions should not be treated indefinitely.

Biopsy thresholds

If a lesion does not behave as expected, the plan should change.

How the research shapes the answer

The clinical reality is that dyspareunia can involve vulval skin disease, inflammatory vaginitis, infection, allergy, scarring, fissures, pelvic-floor bracing, deep pain or focal lesions.

The benchmark shaped search intent and section order, while final wording keeps anatomy precise, avoids self-treatment instructions and preserves biopsy vigilance.





Patient safety

Why this matters

Painful sex is not a single diagnosis. It can affect intimacy and confidence, but the clinical priority is to identify the cause without shame or false reassurance.

It prevents delayed diagnosis

Persistent focal lesions need a lower threshold for specialist review.

It respects mimics

VIN, early cancer and inflammatory dermatoses can overlap in appearance.

It defines biopsy thresholds

Non-healing, changing, bleeding, thickened or atypical lesions should not be treated indefinitely.

It uses safety-net follow-up

If a lesion does not behave as expected, the plan should change.

Cause-led care prevents harm

Repeatedly treating pain as thrush, dryness, friction or anxiety can delay the right diagnosis.

A better approach connects history, examination, tests, skin findings and follow-up so treatment matches the actual driver.





Considerations

What to consider

• General Vulval Care: Avoid soaps, shampoos, and bubble baths. Use bland emollient ointments as soap substitutes and regular moisturisers to preserve the skin barrier. • Diagnostic Biopsies: A 4-6mm punch biopsy under local anaesthesia is the standard for diagnosis. Biopsies must.

Consultation priorities

Useful details include pain location, discharge, odour, bleeding, visible lesions, itching, products, condoms, prior surgery, cycle timing, recurrent infections and vulval skin history.

Location
Discharge
Triggers
Lesions

Duration

A lesion that persists despite appropriate care needs review.

Appearance

Colour change, ulceration, thickening, bleeding or lumpiness matters.

Previous treatment

Poor response to treatment can raise the need for biopsy.

Risk context

Long-standing vulval disease or immunosuppression can change vigilance.

What not to assume

Do not assume persistent dyspareunia is only dryness, only thrush, only friction or only anxiety.

• Topical Steroid Induction: For LS and LP, standard induction involves an ultra-potent steroid applied daily for one month, alternate days for the second month, and twice weekly for the third month, followed by long-term maintenance. • VIN Treatment and Follow-up: VIN.





Common concerns and myths

Common misconceptions

Painful sex content can become too vague. These corrections keep the answer clinically safer.

Myth: Painful lesions are usually just irritation

Reality: persistent focal lesions should not be watched indefinitely.

Myth: VIN always looks obviously cancerous

Reality: persistent focal lesions should not be watched indefinitely.

Myth: A persistent lesion can be watched indefinitely

Reality: persistent focal lesions should not be watched indefinitely.

Precision matters

The vulva, vestibule, vagina, introitus, perineal folds and Bartholin gland area can produce different pain patterns.

Persistence changes the threshold

When symptoms persist, recur or do not respond as expected, reassessment is safer than repeating the same explanation.





Safety checklist

Safety checklist

Use these checks to decide whether symptoms can be discussed routinely or need prompt clinical advice.

Is there a visible lesion?

A plaque, fissure, ulcer, lump, colour change, thickened area or non-healing spot should be assessed.

Is discharge present?

Purulent discharge, odour, recurrent thrush-like symptoms or new irritation may need swabs, microscopy or clinician review.

Is pain focal or recurrent?

Vestibular pain, one-sided entry pain, scar pain, fissuring or deep pain can point to different causes.

Has treatment failed?

Repeated antifungals, steroids, lubricants or antibiotics without improvement should prompt reassessment.

More reassuring signs

Symptoms are more reassuring when they are mild, short-lived, improving, already assessed and not linked with bleeding, sores, swelling, fever, discharge or a persistent lesion.

Mild
Improving
Reviewed

Reasons to seek advice

• Urgent Cancer Referrals: Patients presenting with an unexplained vulval lump, persistent ulceration, or unexplained vulval bleeding must be referred on an urgent 2-week suspected cancer pathway. • Malignancy Risk in dVIN: HPV-independent dVIN (often occurring on a background of LS) carries.

Lesion
Bleeding
Discharge




When to escalate

When to seek medical help

Some symptoms should not be managed as routine painful sex, dryness or recurrent thrush.

Use NHS 111 online

Persistent or changing lesion

A painful, thickened, pigmented, ulcerated, bleeding or non-healing lesion should be assessed promptly.

Bleeding, ulceration or swelling

Bleeding after sex, visible ulceration, new swelling or a lump should not be ignored.

Severe discharge, fever or pelvic pain

Purulent discharge, foul odour, fever, pelvic pain, urinary symptoms or feeling unwell needs clinical advice.

Emergency symptoms

Call 999 for life-threatening symptoms such as collapse, chest pain, breathing difficulty or stroke-like symptoms.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

Additional clinical context

How to use this answer

This page is designed to separate vulval skin disease, inflammatory vaginitis, infection, allergy, scarring, fissuring, post-surgical anatomy, focal lesions and pain sensitisation.

What to discuss at appointment

Useful details include the exact pain point, visible changes, discharge, odour, bleeding, itch, swelling, products used, condom exposure, cycle timing, prior surgery, previous treatments and whether symptoms are changing.

Next step

Book a clinical consultation

A consultation can review lesion appearance, duration, pain, bleeding, prior treatment response, dermatosis history and whether biopsy or urgent specialist referral is needed.

View Research Sources (12 Sources)
• NHS - Pain during or after sex
• NHS - Vulval cancer
• RCOG - Skin conditions of the vulva
• British Society for the Study of Vulval Disease
• PubMed - vulval intraepithelial neoplasia inflammatory dermatoses differential
• PubMed - persistent painful vestibular lesion biopsy squamous cell carcinoma
• NHS - Vaginitis
• NICE CKS - Vaginal discharge
• British Association of Dermatologists - Patient information leaflets
• NHS - Thrush in men and women
• PubMed - desquamative inflammatory vaginitis diagnosis treatment
• PubMed - vulval lichen planus plasma cell vulvitis differential

These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 62 imported records. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.